Home > Qtrly Results > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Quarterly Results Analysis [Dec2025]

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
Audited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
Audited
Revenues ₹73 Cr ₹56 Cr ₹71 Cr ₹76 Cr ₹73 Cr ₹77 Cr ₹66 Cr ₹60 Cr
Expenses ₹69 Cr ₹55 Cr ₹67 Cr ₹64 Cr ₹69 Cr ₹67 Cr ₹56 Cr ₹46 Cr
Operating Income ₹3 Cr ₹1 Cr ₹4 Cr ₹13 Cr ₹4 Cr ₹11 Cr ₹10 Cr ₹13 Cr
Other Income ₹0 Cr ₹2 Cr ₹-2 Cr ₹-2 Cr ₹4 Cr ₹-4 Cr ₹-2 Cr ₹-2 Cr
Interest ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹1 Cr
Depreciation ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr
Profit Before Tax ₹2 Cr ₹1 Cr ₹1 Cr ₹10 Cr ₹6 Cr ₹6 Cr ₹7 Cr ₹11 Cr
Profit After Tax ₹0 Cr ₹0 Cr ₹0 Cr ₹9 Cr ₹5 Cr ₹5 Cr ₹6 Cr ₹11 Cr
EPS ₹0.06 ₹0.04 ₹0.05 ₹1.56 ₹0.97 ₹0.83 ₹1.17 ₹2.01
Industry Peers & Returns1W1M1Y
BALAXI PHARMACEUTICALS -4.9% -15.5% -68.4%
ADANI ENTERPRISES -4.8% -0.6% -2.5%
REDINGTON -3.2% -3.8% 14.4%
MMTC -3.3% -11% -1.8%
HONASA CONSUMER 2.6% 4.7% 39.6%
LLOYDS ENTERPRISES -5.6% -6.6% 22.4%
ENTERO HEALTHCARE SOLUTIONS -0.7% -4.6% -19.3%
OPTIEMUS INFRACOM -4.9% -8.9% -34.8%
POLO QUEEN INDUSTRIAL & FINTECH -2.9% -17.8% -84%

BALAXI PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

29.14 %

Y-o-Y

-1.02 %

Quarters Revenues % Change
Dec2025 ₹73 Cr
29.14
Sep2025 ₹56 Cr
-20.59
Jun2025 ₹71 Cr
-7.24
Mar2025 ₹76 Cr
4.06
Dec2024 ₹73 Cr
-5.29
Sep2024 ₹77 Cr
17.92
Jun2024 ₹66 Cr
9.68
Mar2024 ₹60 Cr -

BALAXI PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

164.47 %

Y-o-Y

-22.52 %

Quarters Operating Profit % Change
Dec2025 ₹3 Cr
164.47
Sep2025 ₹1 Cr
-71.84
Jun2025 ₹4 Cr
-66.96
Mar2025 ₹13 Cr
214.85
Dec2024 ₹4 Cr
-62.34
Sep2024 ₹11 Cr
4.97
Jun2024 ₹10 Cr
-25.10
Mar2024 ₹13 Cr -
Operating Margins
Q-o-Q

104.81 %

Y-o-Y

-21.69 %

Quarters Operating Margin% % Change
Dec2025 4.26%
104.81
Sep2025 2.08%
-64.51
Jun2025 5.86%
-64.40
Mar2025 16.46%
202.57
Dec2024 5.44%
-60.23
Sep2024 13.68%
-11.00
Jun2024 15.37%
-31.72
Mar2024 22.51% -

BALAXI PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

46.15 %

Y-o-Y

-94.33 %

Quarters Profit After Tax % Change
Dec2025 ₹0 Cr
46.15
Sep2025 ₹0 Cr
-28.52
Jun2025 ₹0 Cr
-96.63
Mar2025 ₹9 Cr
61.10
Dec2024 ₹5 Cr
16.87
Sep2024 ₹5 Cr
-29.20
Jun2024 ₹6 Cr
-40.73
Mar2024 ₹11 Cr -
PAT Margins
Q-o-Q

13.51 %

Y-o-Y

-94.26 %

Quarters PAT Margin(%) % Change
Dec2025 0.42 %
13.51
Sep2025 0.37 %
-9.76
Jun2025 0.41 %
-96.38
Mar2025 11.33 %
54.78
Dec2024 7.32 %
23.44
Sep2024 5.93 %
-39.92
Jun2024 9.87 %
-45.98
Mar2024 18.27 % -

BALAXI PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

50.00 %

Y-o-Y

-93.81 %

Quarters EPS % Change
Dec2025 ₹0.06
50.00
Sep2025 ₹0.04
-20.00
Jun2025 ₹0.05
-96.79
Mar2025 ₹1.56
60.82
Dec2024 ₹0.97
16.87
Sep2024 ₹0.83
-29.06
Jun2024 ₹1.17
-41.79
Mar2024 ₹2.01 -

You may also like the below Video Courses